Skip to main content
Top
Gepubliceerd in: Quality of Life Research 3/2012

01-04-2012

Measuring outcomes in Parkinson’s disease: a multi-perspective concept mapping study

Auteurs: Catharina Sjödahl Hammarlund, Maria H. Nilsson, Peter Hagell

Gepubliceerd in: Quality of Life Research | Uitgave 3/2012

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

To identify and develop a conceptual map of prioritized areas and to determine their relative importance for outcome measurement in clinical Parkinson’s disease (PD) trials, from the perspectives of health care professionals and people with PD.

Method

We used concept mapping, a qualitative/quantitative method consisting of three steps: item generation through focus groups (n = 27; 12 people with PD, 12 health care professionals, 3 researchers), item sorting and rating (n = 38; 19 people with PD, 19 health care professionals), and data analysis (multidimensional scaling, cluster analysis).

Results

Ninety-nine items and eight clusters were generated. Clusters representing Participation; Mobility and motor functioning; Cognitive and executive functioning; and Emotions were the most homogenous. Statements within clusters representing Energy and abilities; Autonomic dysfunctions; Sensory, speech and swallowing problems; and Neuropsychiatric symptoms also related to statements outside their respective clusters. Clusters rated most important were Participation and Mobility and motor functioning, and the highest rated items were quality of life, walking ability, and sleeping problems.

Conclusion

By the use of concept mapping, a multi-perspective conceptual map of prioritized aspects for the outcome measurement in PD was defined. These findings provide an initial conceptual basis toward improved outcome measurement priorities in clinical PD trials.
Literatuur
1.
go back to reference Lees, A. J., Hardy, J., & Revesz, T. (2009). Parkinson’s disease. Lancet, 373(9680), 2055–2066.PubMedCrossRef Lees, A. J., Hardy, J., & Revesz, T. (2009). Parkinson’s disease. Lancet, 373(9680), 2055–2066.PubMedCrossRef
2.
go back to reference Chaudhuri, K. R., Healy, D. G., & Schapira, A. H. (2006). Non-motor symptoms of Parkinson’s disease: Diagnosis and management. Lancet Neurology, 5(3), 235–245.PubMedCrossRef Chaudhuri, K. R., Healy, D. G., & Schapira, A. H. (2006). Non-motor symptoms of Parkinson’s disease: Diagnosis and management. Lancet Neurology, 5(3), 235–245.PubMedCrossRef
3.
go back to reference Karlsen, K. H., Larsen, J. P., Tandberg, E., & Maeland, J. G. (1999). Influence of clinical and demographic variables on quality of life in patients with Parkinson’s disease. Journal of Neurology, Neurosurgery and Psychiatry, 66(4), 431–435.CrossRef Karlsen, K. H., Larsen, J. P., Tandberg, E., & Maeland, J. G. (1999). Influence of clinical and demographic variables on quality of life in patients with Parkinson’s disease. Journal of Neurology, Neurosurgery and Psychiatry, 66(4), 431–435.CrossRef
4.
go back to reference Soh, S. E., Morris, M. E., & McGinley, J. L. (2011). Determinants of health-related quality of life in Parkinson’s disease: A systematic review. Parkinsonism and Related Disorders, 17(1), 1–9.PubMedCrossRef Soh, S. E., Morris, M. E., & McGinley, J. L. (2011). Determinants of health-related quality of life in Parkinson’s disease: A systematic review. Parkinsonism and Related Disorders, 17(1), 1–9.PubMedCrossRef
5.
go back to reference Gruber-Baldini, A. L., Ye, J., Anderson, K. E., & Shulman, L. M. (2009). Effects of optimism/pessimism and locus of control on disability and quality of life in Parkinson’s disease. Parkinsonism and Related Disorders, 15(9), 665–669.PubMedCrossRef Gruber-Baldini, A. L., Ye, J., Anderson, K. E., & Shulman, L. M. (2009). Effects of optimism/pessimism and locus of control on disability and quality of life in Parkinson’s disease. Parkinsonism and Related Disorders, 15(9), 665–669.PubMedCrossRef
6.
go back to reference Koplas, P. A., Gans, H. B., Wisely, M. P., Kuchibhatla, M., Cutson, T. M., Gold, D. T., et al. (1999). Quality of life and Parkinson’s disease. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 54(4), M197–M202.CrossRef Koplas, P. A., Gans, H. B., Wisely, M. P., Kuchibhatla, M., Cutson, T. M., Gold, D. T., et al. (1999). Quality of life and Parkinson’s disease. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 54(4), M197–M202.CrossRef
7.
go back to reference Wallhagen, M. I., & Brod, M. (1997). Perceived control and well-being in Parkinson’s disease. Western Journal of Nursing Research, 19(1), 11–25. (discussion 25–31).PubMedCrossRef Wallhagen, M. I., & Brod, M. (1997). Perceived control and well-being in Parkinson’s disease. Western Journal of Nursing Research, 19(1), 11–25. (discussion 25–31).PubMedCrossRef
8.
go back to reference Charlton, G. S., & Barrow, C. J. (2002). Coping and self-help group membership in Parkinson’s disease: An exploratory qualitative study. Health & Social Care in the Community, 10(6), 472–478.CrossRef Charlton, G. S., & Barrow, C. J. (2002). Coping and self-help group membership in Parkinson’s disease: An exploratory qualitative study. Health & Social Care in the Community, 10(6), 472–478.CrossRef
9.
go back to reference Andersson, I., & Sidenvall, B. (2001). Case studies of food shopping, cooking and eating habits in older women with Parkinson’s disease. Journal of Advanced Nursing, 35(1), 69–78.PubMedCrossRef Andersson, I., & Sidenvall, B. (2001). Case studies of food shopping, cooking and eating habits in older women with Parkinson’s disease. Journal of Advanced Nursing, 35(1), 69–78.PubMedCrossRef
10.
go back to reference Keller, H. H., Edward, H. G., & Cook, C. (2006). Mealtime experiences of families with dementia. American Journal of Alzheimers Disease and Other dementias, 21(6), 431–438.CrossRef Keller, H. H., Edward, H. G., & Cook, C. (2006). Mealtime experiences of families with dementia. American Journal of Alzheimers Disease and Other dementias, 21(6), 431–438.CrossRef
11.
go back to reference Lim, A., Leow, L., Huckabee, M. L., Frampton, C., & Anderson, T. (2008). A pilot study of respiration and swallowing integration in Parkinson’s disease: “On” and “off” levodopa. Dysphagia, 23(1), 76–81.PubMedCrossRef Lim, A., Leow, L., Huckabee, M. L., Frampton, C., & Anderson, T. (2008). A pilot study of respiration and swallowing integration in Parkinson’s disease: “On” and “off” levodopa. Dysphagia, 23(1), 76–81.PubMedCrossRef
12.
go back to reference Miller, N., Noble, E., Jones, D., & Burn, D. (2006). Hard to swallow: Dysphagia in Parkinson’s disease. Age and Ageing, 35(6), 614–618.PubMedCrossRef Miller, N., Noble, E., Jones, D., & Burn, D. (2006). Hard to swallow: Dysphagia in Parkinson’s disease. Age and Ageing, 35(6), 614–618.PubMedCrossRef
13.
go back to reference Low, J. (2006). Communication problems between researchers and informants with speech difficulties: Methodological and analytic issues. Field Methods, 18(2), 153–171.CrossRef Low, J. (2006). Communication problems between researchers and informants with speech difficulties: Methodological and analytic issues. Field Methods, 18(2), 153–171.CrossRef
14.
go back to reference Hobart, J. C., Cano, S. J., Zajicek, J. P., & Thompson, A. J. (2007). Rating scales as outcome measures for clinical trials in neurology: Problems, solutions, and recommendations. Lancet Neurology, 6(12), 1094–1105.PubMedCrossRef Hobart, J. C., Cano, S. J., Zajicek, J. P., & Thompson, A. J. (2007). Rating scales as outcome measures for clinical trials in neurology: Problems, solutions, and recommendations. Lancet Neurology, 6(12), 1094–1105.PubMedCrossRef
15.
go back to reference Mitchell, S. L., Harper, D. W., Lau, A., & Bhalla, R. (2000). Patterns of outcome measurement in Parkinson’s disease clinical trials. Neuroepidemiology, 19(2), 100–108.PubMedCrossRef Mitchell, S. L., Harper, D. W., Lau, A., & Bhalla, R. (2000). Patterns of outcome measurement in Parkinson’s disease clinical trials. Neuroepidemiology, 19(2), 100–108.PubMedCrossRef
16.
go back to reference Chalmers, I. (2007). The Alzheimer’s society, drug firms, and public trust. BMJ, 335, 400.CrossRef Chalmers, I. (2007). The Alzheimer’s society, drug firms, and public trust. BMJ, 335, 400.CrossRef
17.
go back to reference Food and Drug Administration. (2009). Patient-reported outcome measures: Use in medicinal product development to support labelling claims. Washington, DC. Food and Drug Administration. (2009). Patient-reported outcome measures: Use in medicinal product development to support labelling claims. Washington, DC.
18.
go back to reference Nisenzon, A. N., Robinson, M. E., Bowers, D., Banou, E., Malaty, I., & Okun, M. S. (2011). Measurement of patient-centered outcomes in Parkinson’s disease: What do patients really want from their treatment? Parkinsonism and Related Disorders, 17(2), 89–94.PubMedCrossRef Nisenzon, A. N., Robinson, M. E., Bowers, D., Banou, E., Malaty, I., & Okun, M. S. (2011). Measurement of patient-centered outcomes in Parkinson’s disease: What do patients really want from their treatment? Parkinsonism and Related Disorders, 17(2), 89–94.PubMedCrossRef
19.
go back to reference Kane, M., & Trochim, W. M. K. (2007). Concept mapping for planning and evaluation. Thousand Oaks: Sage Publications, Inc. Kane, M., & Trochim, W. M. K. (2007). Concept mapping for planning and evaluation. Thousand Oaks: Sage Publications, Inc.
20.
go back to reference Trochim, W. M. K. (1989). An introduction to concept mapping for planning and evaluation. Evaluation and Program Planning, 12(1), 1–16.CrossRef Trochim, W. M. K. (1989). An introduction to concept mapping for planning and evaluation. Evaluation and Program Planning, 12(1), 1–16.CrossRef
21.
go back to reference Akhtar-Danesh, N., Baumann, A., & Cordingley, L. (2008). Q-methodology in nursing research: A promising method for the study of subjectivity. Western Journal of Nursing Research, 30(6), 759–773.PubMedCrossRef Akhtar-Danesh, N., Baumann, A., & Cordingley, L. (2008). Q-methodology in nursing research: A promising method for the study of subjectivity. Western Journal of Nursing Research, 30(6), 759–773.PubMedCrossRef
22.
go back to reference Patton, M. Q. (2002). Qualitative evaluation and research methods (3rd ed.). Thousand Oaks: Sage Publications. Patton, M. Q. (2002). Qualitative evaluation and research methods (3rd ed.). Thousand Oaks: Sage Publications.
23.
go back to reference Hoehn, M. M., & Yahr, M. D. (1967). Parkinsonism: Onset, progression and mortality. Neurology, 17(5), 427–442.PubMed Hoehn, M. M., & Yahr, M. D. (1967). Parkinsonism: Onset, progression and mortality. Neurology, 17(5), 427–442.PubMed
24.
go back to reference Goetz, C. G., Poewe, W., Rascol, O., Sampaio, C., Stebbins, G. T., Counsell, C., et al. (2004). Movement Disorder Society Task Force report on the Hoehn and Yahr Staging Scale: Status and recommendations. Movement Disorders, 19(9), 1020–1028.PubMedCrossRef Goetz, C. G., Poewe, W., Rascol, O., Sampaio, C., Stebbins, G. T., Counsell, C., et al. (2004). Movement Disorder Society Task Force report on the Hoehn and Yahr Staging Scale: Status and recommendations. Movement Disorders, 19(9), 1020–1028.PubMedCrossRef
25.
go back to reference Hagell, P., & Sandlund, B. (2000). Patients’ self-assessment of disease and symptom severity in Parkinson’s disease. Quality of Life Research, 9(3), 285. Hagell, P., & Sandlund, B. (2000). Patients’ self-assessment of disease and symptom severity in Parkinson’s disease. Quality of Life Research, 9(3), 285.
26.
go back to reference Hobson, J. P., Edwards, N. I., & Meara, R. J. (2001). The Parkinson’s Disease Activities of Daily Living Scale: A new simple and brief subjective measure of disability in Parkinson’s disease. Clinical Rehabilitation, 15(3), 241–246.PubMedCrossRef Hobson, J. P., Edwards, N. I., & Meara, R. J. (2001). The Parkinson’s Disease Activities of Daily Living Scale: A new simple and brief subjective measure of disability in Parkinson’s disease. Clinical Rehabilitation, 15(3), 241–246.PubMedCrossRef
27.
go back to reference Severens, P. (1995). Handbook: Concept mapping. Amsterdam: National Centre for Mental Health/Talcott BV. Severens, P. (1995). Handbook: Concept mapping. Amsterdam: National Centre for Mental Health/Talcott BV.
28.
go back to reference Knutsson, I., Rydstrom, H., Reimer, J., Nyberg, P., & Hagell, P. (2010). Interpretation of response categories in patient-reported rating scales: A controlled study among people with Parkinson’s disease. Health and Quality of Life Outcomes, 8, 61.PubMedCrossRef Knutsson, I., Rydstrom, H., Reimer, J., Nyberg, P., & Hagell, P. (2010). Interpretation of response categories in patient-reported rating scales: A controlled study among people with Parkinson’s disease. Health and Quality of Life Outcomes, 8, 61.PubMedCrossRef
29.
go back to reference Trochim, W. M., Stillman, F. A., Clark, P. I., & Schmitt, C. L. (2003). Development of a model of the tobacco industry’s interference with tobacco control programmes. Tobacco Control, 12(2), 140–147.PubMedCrossRef Trochim, W. M., Stillman, F. A., Clark, P. I., & Schmitt, C. L. (2003). Development of a model of the tobacco industry’s interference with tobacco control programmes. Tobacco Control, 12(2), 140–147.PubMedCrossRef
30.
go back to reference Rahman, S., Griffin, H. J., Quinn, N. P., & Jahanshahi, M. (2008). Quality of life in Parkinson’s disease: The relative importance of the symptoms. Movement Disorders, 23(10), 1428–1434.PubMedCrossRef Rahman, S., Griffin, H. J., Quinn, N. P., & Jahanshahi, M. (2008). Quality of life in Parkinson’s disease: The relative importance of the symptoms. Movement Disorders, 23(10), 1428–1434.PubMedCrossRef
31.
go back to reference Friedman, J. H., Brown, R. G., Comella, C., Garber, C. E., Krupp, L. B., Lou, J. S., et al. (2007). Fatigue in Parkinson’s disease: A review. Movement Disorders, 22(3), 297–308.PubMedCrossRef Friedman, J. H., Brown, R. G., Comella, C., Garber, C. E., Krupp, L. B., Lou, J. S., et al. (2007). Fatigue in Parkinson’s disease: A review. Movement Disorders, 22(3), 297–308.PubMedCrossRef
32.
go back to reference Peto, V., Jenkinson, C., Fitzpatrick, R., & Greenhall, R. (1995). The development and validation of a short measure of functioning and well being for individuals with Parkinson’s disease. Quality of Life Research, 4(3), 241–248.PubMedCrossRef Peto, V., Jenkinson, C., Fitzpatrick, R., & Greenhall, R. (1995). The development and validation of a short measure of functioning and well being for individuals with Parkinson’s disease. Quality of Life Research, 4(3), 241–248.PubMedCrossRef
33.
go back to reference Ware, J. E., Jr., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30(6), 473–483.PubMedCrossRef Ware, J. E., Jr., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30(6), 473–483.PubMedCrossRef
34.
go back to reference Hagell, P., Reimer, J., & Nyberg, P. (2009). Whose quality of life? Ethical implications in patient-reported health outcome measurement. Value Health, 12(4), 613–617.PubMedCrossRef Hagell, P., Reimer, J., & Nyberg, P. (2009). Whose quality of life? Ethical implications in patient-reported health outcome measurement. Value Health, 12(4), 613–617.PubMedCrossRef
35.
go back to reference Lee, M. A., Walker, R. W., Hildreth, A. J., & Prentice, W. M. (2006). Individualized assessment of quality of life in idiopathic Parkinson’s disease. Movement Disorders, 21(11), 1929–1934.PubMedCrossRef Lee, M. A., Walker, R. W., Hildreth, A. J., & Prentice, W. M. (2006). Individualized assessment of quality of life in idiopathic Parkinson’s disease. Movement Disorders, 21(11), 1929–1934.PubMedCrossRef
36.
go back to reference Osborne, R. H., Elsworth, G. R., & Whitfield, K. (2007). The Health Education Impact Questionnaire (heiQ): An outcomes and evaluation measure for patient education and self-management interventions for people with chronic conditions. Patient Education and Counseling, 66(2), 192–201.PubMedCrossRef Osborne, R. H., Elsworth, G. R., & Whitfield, K. (2007). The Health Education Impact Questionnaire (heiQ): An outcomes and evaluation measure for patient education and self-management interventions for people with chronic conditions. Patient Education and Counseling, 66(2), 192–201.PubMedCrossRef
Metagegevens
Titel
Measuring outcomes in Parkinson’s disease: a multi-perspective concept mapping study
Auteurs
Catharina Sjödahl Hammarlund
Maria H. Nilsson
Peter Hagell
Publicatiedatum
01-04-2012
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 3/2012
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-011-9995-3

Andere artikelen Uitgave 3/2012

Quality of Life Research 3/2012 Naar de uitgave